RevolKa Closes $1.7M Series A Extension For Drug Discovery Programs
29 Aug 2024 //
BUSINESSWIRE
RevolKa enters master service agreement with Daiichi Sankyo
29 May 2024 //
PHARMABIZ
RevolKa Signs Master Service Agreement with Daiichi Sankyo
28 May 2024 //
CONTRACT PHARMA
RevolKa Signed Master Service Agreement with Daiichi Sankyo
27 May 2024 //
BUSINESSWIRE